Mariam Alexander/getcare.muschealth.org
Jul 4, 2025, 14:56
Mariam Alexander: More Options for NSCLC with EGFR Exon 20 Insertion Mutation
Mariam Alexander, Thoracic Medical Oncologist at MUSC Health University Medical Center, shared a post on X:
“More options for this rare disease. Would this work after zipalertinib (trial patient)? FDA grants accelerated approval to sunvozertinib for NSCLC with EGFR exon 20 insertion mutation.”
More posts featuring Mariam Alexander.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2025, 19:13
Sep 6, 2025, 19:01
Sep 6, 2025, 18:05
Sep 6, 2025, 17:52
Sep 6, 2025, 17:48
Sep 6, 2025, 17:39
Sep 6, 2025, 17:28